CMR Surgical Begins Pediatric Trial of Versius Surgical Robot

CMR Surgical has initiated a multicenter, prospective clinical trial that will evaluate the Versius surgical robotic system in pediatric surgery.
 
The trial will focus on 150 children and infants undergoing a range of urological procedures. It will be performed in partnership with three clinical sites across the NHS. The trial will also include a thorough clinical follow-up of surgical outcomes, recovery, and clinical outcomes for up to a year after the surgery.
 
The Department of Paediatric Urology at Southampton Children’s Hospital—the primary site of the trial led by Ewan Brownlee—has become the first to perform pediatric urology surgery with Versius in a clinical trial.
 
The Department of Paediatric Urology at Royal Manchester Children’s Hospital part of Manchester University NHS Foundation Trust, led by David Keene; and Department of Paediatric Urology, and the Evelina London Children’s Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust, led by Pankaj Mishra make up the remaining sites taking part in the clinical trial.
 
“We are delighted to begin the world’s first pediatric trials using Versius, in the UK,” said CMR Surgical co-founder and chief medical officer Mark Slack. “The small, modular design of Versius, and small instrument diameter provides an opportunity to be able to perform robotic-assisted surgery for the treatment of pediatric patients.  We are committed to the responsible introduction of Versius across new specialties and we look forward to working with our partners as we undertake this clinical trial to ensure the safety and efficacy of Versius in pediatrics.”

More about the Versius robot

The small, modular, versatile surgical robot is used for “keyhole surgery”—robotic-assisted minimal access surgery. Versius’ small and modular design lets the system be set up in a way to give the surgeon optimal access in small, hard-to-reach spaces in the operating zone while maintaining clear access to the patient.
 
Versius has been used in over 23,000 surgical cases with more than 130 different surgical procedures performed across seven surgical specialties. The system is in routine use across urology, general surgery, gynecology, colorectal surgery, and thoracic surgery. Versius is also being used in an ongoing clinical trial assessing the suitability of the system for use in transoral robotic surgery.
 
Earlier this year, CMR Surgical launched vLimeLite for the Versius Plus robot. vLimeLite is an integrated fluorescence imaging system to visualize ICG (Indocyanine green).